Sales & Marketing Preparing for a post-pandemic world Janssen’s Mark Hicken, VP of strategy, EMEA, looks at what COVID-19 has taught us and how we can become stronger as we emerge from the pandemic.
Views & Analysis Never waste a crisis: Can a new life sciences strategy be f... Andrew McConaghie speaks to UK pharma industry leaders about Brexit and what is needed to create a meaningful, long-term life sciences strategy.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.